AzTrials
AzTrials

Laparoscopic SurgeryNCT05565508

Safe Laparoscopic Access in Patients With Previous Abdominal and Pelvic Surgery

A study testing new laparoscopic access technique for group a and Hasson's technique for laparoscopic access in group b in people with Laparoscopic Surgery, run by Zagazig University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

the study discussed the safety of new technique for primary port insertion in cases of previous abdominal and pelvic surgery Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Laparoscopic Surgery
What is being tested?
new laparoscopic access technique for group a and Hasson's technique for laparoscopic access in group b
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
172 participants
Where
1 siteEgypt
Study dates
20 Mar 2020to 20 Jul 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Patients more than 18 year-old with history of previous abdominal and/or pelvic surgery.
  • underwent laparoscopic surgery in general surgery departments in both centers from March, 2020 to july, 2022.

Who cannot join

  • Patients with distended abdomen due to bowel obstruction.
  • Patients with uncorrected coagulopathy.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Zagazig University

    Zagazig

Other trials in Egypt

About this study

Official title: a Prospective Randomized Controlled Trial Evaluating Safe Laparoscopic Access in Patients With Previous Abdominal and Pelvic Surgery

the study discussed the safety of new technique for primary port insertion in cases of previous abdominal and pelvic surgery

Read the detailed description

the study discussed the safety of new technique for primary port insertion in cases of previous abdominal and pelvic surgery and comparing the new technique group (A) patients to already known technique called (Hasson's technique) group (B) patients

Being tested
new laparoscopic access technique for group a, Hasson's technique for laparoscopic access in group b

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • new laparoscopic access technique for group aProcedure or surgery

    Also called new laparoscopic access technique

    new laparoscopic access technique through the epigastric region

  • Hasson's technique for laparoscopic access in group bProcedure or surgery

    Hasson's technique for laparoscopic access in group b

Study groups in NCT05565508
Study groupRoleWhat they receive
new laparoscopic access techniqueExperimentalin which we used our new laparoscopic access
Receives: Procedure: new laparoscopic access technique for group a
Hasson's techniqueExperimentalin which we used the well-known Hasson's technique for primary laparoscopic access
Receives: Procedure: Hasson's technique for laparoscopic access in group b

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. time needed to access the peritoneal cavity

    time needed to access the peritoneal cavity

    Measured: the first 15 minutes of operation

  2. numbers of trials till the good peritoneal access achieved

    numbers of trials till the good peritoneal access achieved

    Measured: the first 15 minutes of operation

Secondary outcomes (1)
  1. rate of complications

    rate of complications

    Measured: the first 15 minutes of operation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Oct 2022
  2. Study start20 Mar 2020
  3. Primary completion17 Jul 2022
  4. Study completion20 Jul 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
172 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05565508
Sponsor's protocol ID
zuh248
Status last verified
Oct 2022
First submitted
27 Sep 2022
Last updated
4 Oct 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing new laparoscopic access technique for group a and Hasson's technique for laparoscopic access in group b in people with Laparoscopic Surgery, run by Zagazig University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Oct 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

time needed to access the peritoneal cavity (time frame: the first 15 minutes of operation). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Oct 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in